Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes

Nov 13, 2020Current neurovascular research

Nicotinamide's role in controlling metabolism through SIRT1, mTOR, and body clock genes

AI simplified

Abstract

Nicotinamide may improve glucose utilization and limit mitochondrial dysfunction in metabolic disorders.

  • Metabolic disorders, including diabetes, affect all body systems and current treatments do not prevent disease progression.
  • Nicotinamide interacts with key pathways like SIRT1, mTOR, AMPK, and clock genes that are involved in metabolic regulation.
  • The compound could help reduce oxidative stress and support cellular survival through mechanisms such as autophagy.
  • Complex interactions among nicotinamide, SIRT1, mTOR, and other factors may influence metabolic homeostasis.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free